Cancer Care Ontario | Cancer Care Ontario

20 Results

Cancer facts

Updated cancer prevention guidelines incorporate a holistic view of nutrition

Feb 2019

Guidelines and Advice

Use of the Epidermal Growth Factor Receptor Inhibitors Gefitinib (Iressa®), Erlotinib (Tarceva®), Afatinib, Dacomitinib or Icotinib in the Treatment of Non–SmallCell Lung Cancer: A Clinical Practice Guideline

Status: In-Review
ID: 7-9
Version: 2

Apr 2014

Quality Improvement Resources for Surgical Oncology

Learn, discuss and provide feedback on quality issues in cancer care with these educational tools for Ontario physicians. These resources have been...

Quality Expectations by Disease Site – Radiation Treatment

Guidelines and Advice

Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer

Status: Current
ID: GL 1-22-A
Version: 2

Jul 2022

Guidelines and Advice

Use of Preoperative Chemotherapy With or Without Postoperative Radiotherapy in Technically Resectable Stage IIIA Non-Small Cell Lung Cancer

Status: Archived
ID: 7-4
Version: 2

Dec 2017

Guidelines and Advice

Use of Amifostine to Ameliorate the Toxic Effects of Chemotherapy in the Treatment of Cancer

Status: Archived
ID: 12-6

May 2012

Guidelines and Advice

Use of 5-HT3 Receptor Antagonists in Patients Receiving Moderately or Highly Emetogenic Chemotherapy

Status: Archived
ID: 12-3

Jan 2003

Guidelines and Advice

Use of Gemcitabine in the Treatment of Advanced Pancreatic Adenocarcinoma

Status: Archived
ID: 2-10

Sep 2011

Guidelines and Advice

Use of Irinotecan in the Second-Line Treatment of Metastatic Colorectal Cancer

Status: Archived
ID: 2-16

Sep 2011

Guidelines and Advice

Use of Irinotecan (Camptosar®, CPT-11) Combined with 5-Fluorouracil and Leucovorin (5FU/LV) as First-Line Therapy for Metastatic Colorectal Cancer

Status: Archived
ID: 2-16b
Version: 2

Sep 2011

Guidelines and Advice

Use of Raltitrexed (Tomudex) in the Management of Metastatic Colorectal Cancer

Status: Archived
ID: 2-17

Sep 2011

Updated cancer prevention guidelines incorporate a holistic view of nutrition

Use of the Epidermal Growth Factor Receptor Inhibitors Gefitinib (Iressa®), Erlotinib (Tarceva®), Afatinib, Dacomitinib or Icotinib in the Treatment of Non–SmallCell Lung Cancer: A Clinical Practice Guideline

Quality Improvement Resources for Surgical Oncology

Quality Expectations by Disease Site – Radiation Treatment

Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer

Use of Preoperative Chemotherapy With or Without Postoperative Radiotherapy in Technically Resectable Stage IIIA Non-Small Cell Lung Cancer

Use of Amifostine to Ameliorate the Toxic Effects of Chemotherapy in the Treatment of Cancer

Use of 5-HT3 Receptor Antagonists in Patients Receiving Moderately or Highly Emetogenic Chemotherapy

Use of Gemcitabine in the Treatment of Advanced Pancreatic Adenocarcinoma

Use of Irinotecan in the Second-Line Treatment of Metastatic Colorectal Cancer

Use of Irinotecan (Camptosar®, CPT-11) Combined with 5-Fluorouracil and Leucovorin (5FU/LV) as First-Line Therapy for Metastatic Colorectal Cancer

Use of Raltitrexed (Tomudex) in the Management of Metastatic Colorectal Cancer

Pages